PRA-184881 Central nervous system conditions and neurodevelopmental disorders € 3.320,-

Many places available

Description

Study of a new compound that is being developed for the treatment of central nervous system conditions and neurodevelopmental disorders (such as epilepsy and autism)

Requested participants

  • M/F, Healthy, 18 - 60 years old
  • Non-smokers only

Duration and visits

  • 4× 7 days stay

Learn more about this research?

Research details

Particulars

  • You do not smoke. 
  • Your body weight must be at least 50 kg and your Body Mass Index (BMI) is between 18.5 and 30.0 kg/m2. The BMI shows the relation between body weight in kilograms and height in meters.
  • Women are only allowed to participate in this study if they are using sufficient contraception such as an intrauterine device or hormonal contraceptives in combination with a condom, or have been postmenopausal for at least one year, or have been surgically sterilized at least 6 months ago.
  • You are only allowed to participate, if you did not participate in a drug study within the 3 months prior to the first dosing in this study.
  • To determine if you are suitable to participate in this study, you will undergo a medical screening. 
Calculate BMI

Compensation

You will receive a gross compensation of € 3.320,- for participation in part A (group 1) of this study.

For participation in part B (group 2) of the study, you will receive a gross compensation of € 2.524,-.

Travelling expenses will be reimbursed based on the distance traveled (€ 0,19 net per kilometer) with a minimum of € 12,- and a maximum of € 160,- (840 kilometers) per return, regardless of the mode of transportation.

Period of stay and research

The study consists of 2 parts. You can only participate in one part.

For Part A (group 1) the study consists of 4 periods. For each period, you will stay in our research facility in Groningen for 7 days (6 nights).

For Part B (group 2) the study consists of 3 periods. For each period, you will stay in our research facility in Groningen for 7 days (6 nights).

Finally, there will be a follow-up visit for both groups 14 days after the dosing of the last period of your group.

Please note: You have to be available for all dates for the group of choice to be able to participate in this study. These are the currently planned dates; however, these may be subject to change.

Group 1

€ 3.320,-

4× 7 days stay

  • 8 Apr 2019 up to and including 14 Apr 2019
  • 22 Apr 2019 up to and including 28 Apr 2019
  • 6 May 2019 up to and including 12 May 2019
  • 20 May 2019 up to and including 26 May 2019

short stay

Inapplicable

Call me back

We bellen terug tijdens kantooruren binnen 3 werkdagen.

Bel mij terug
  • ?

  • ?